More than 20 years ago, the U.S. became the leader in the worldwide fight against HIV/AIDS. The Bush administration initiative Pepfar was the largest health commitment made by a nation to combat a ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

Learn how the molecule EBC-46 could advance how HIV is treated and how researchers discovered it.

The first known case of HIV-1 infection in human was detected in 1959, from a blood sample of a man in Kinshasa, Democratic ...

The head of the U.N. AIDS agency says the number of new HIV infections could jump more than six times by 2029 if U.S.

Undergraduate and graduate physics students at UMaine Hess Lab in Orono are currently working on research that if proven, ...

The president is taking a chainsaw to our public health infrastructure—and people will die as a result.

Think of the Trump administration as a virulent but benevolent virus that has infected the monstrous, bloated, Vindmanesque ...

The development of an effective HIV vaccine remains an urgent public health need due to the high genetic variability and rapid mutation rates of the virus, which limit the generation of broadly ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...